IMCD completes the acquisition of South Korean based Whawon Pharm Co. Ltd.
18 Dezembro 2019 - 3:00PM
IMCD completes the acquisition of South Korean based Whawon Pharm
Co. Ltd.
ROTTERDAM, The Netherlands (December 18, 2019) – IMCD
N.V. (“IMCD” or “Company”), a leading distributor of speciality
chemicals and food ingredients, today announces that it has
successfully completed the acquisition of pharmaceutical ingredient
distributor Whawon Pharm Co. Ltd. (“Whawon”).
IMCD acquired 57% of the total share capital from the existing
Whawon management, who will continue to lead the company. The
remaining 43%, will be maintained by the management, for a period
up to 5 years after closing.
- PRESS RELEASE_IMCD completes the acquisition of South Korean
based Whawon Pharm Co. Ltd.
IMCD NV (EU:IMCD)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
IMCD NV (EU:IMCD)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024